Breakthroughs in Atopic Dermatitis with Linda Stein Gold, MD: Primary Viewpoints Podcast

Linda Stein Gold, MD, discusses the late-breaking tapinarof cream 1% data from a new analysis of the ADORING-3 clinical trial. Interview recorded at the 2025 American Academy of Dermatology conference in Orlando, Florida.

Topics discussed include:

• Key insights from the new analysis of the ADORING-3 clinical trial on the use of tapinarof cream, 1% in patients with atopic dermatitis.
• Long-term safety and efficacy of tapinarof cream 1%.
• How tapinarof cream 1% differs from existing treatment options.
• Impacts on clinical practice.

For more 2025 AAD Meeting coverage, please click here.